How an elite rehab center is using GLP-1s to ‘obliterate’ all kinds of cravings

Doctors at Caron Treatment Centers have begun prescribing semaglutide not to address obesity or diabetes but to help treat addiction.

July 19, 2025 Check out STAT+

Sponsored By

Rachel Wisniewski for STAT STAT+ | Ozempic for addiction: How an elite rehab center is using GLP-1s to 'obliterate' all kinds of cravings Caron Treatment Centers use GLP-1 drugs in addiction treatment. Doctors say Ozempic has "obliterated" patients' cravings for opioids and alcohol. By Lev Facher and Rachel Wisniewski Maria Fabrizio for STAT An overlooked demographic has the highest suicide risk — and it's been rising Suicide rates are falling for youth but rising for older men. Experts say loneliness and access to firearms create a deadly combination By Olivia Goldhill Alex Hogan/STAT Why MAHA's push on Coca-Cola and ice cream is 'nutritionally hilarious' Coca-Cola's switch to cane sugar from corn syrup, and ice cream makers' elimination of synthetic dyes, is missing the point on healthier diets, experts say. By Sarah Todd STAT+ | The growing influence of vaccine skeptics inside HHS Lyn Redwood, former president of the anti-vaccine group Children's Health Defense, is the latest vaccine critic hired by HHS Secretary Robert F. Kennedy Jr. By Chelsea Cirruzzo STAT+ | HHS efficiency review blamed for delaying patient care at Indian Health Service New HHS contract reviews were supposed to promote efficiency. IHS insiders say process bottlenecks are delaying care and filling of vacancies By Angus Chen STAT+ | A well-placed biotech investor says U.S. policies are straining life sciences startups Entrepreneur Johannes Fruehauf, co-founder of LabCentral and BioLabs, believes that more disruption is coming. By Allison DeAngelis Opinion: I worked for 20 years for the HHS office that safeguarded people in research studies. DOGE gutted it The OHRP staff with substantive expertise, experience, and institutional memory of regulatory policy are almost all gone. By Ivor Pritchard STAT+ | Undruggable 'disordered' proteins become druggable with new AI techniques from David Baker New research papers outline ways to make certain proteins more receptive to drugs, an important advance because many diseases involve disordered proteins. By Brittany Trang

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Weekend Reads? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2025, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser